(Q40811246)

23 September 2017

title

Prolonged cholestasis after ajmaline-induced acute hepatitis (English)

1 reference

23 September 2017

D Larrey

1

1 reference

23 September 2017

D Pessayre

2

1 reference

23 September 2017

G Duhamel

3

1 reference

23 September 2017

A Casier

4

1 reference

23 September 2017

C Degott

5

1 reference

23 September 2017

G Feldmann

6

1 reference

23 September 2017

S Erlinger

7

1 reference

23 September 2017

J P Benhamou

8

1 reference

23 September 2017

publication date

1 January 1986

1 reference

23 September 2017

published in

Journal of Hepatology

1 reference

23 September 2017

volume

2

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

81-87

1 reference

Cholestatic liver disease associated with diphenylhydantoin therapy. Possible pathogenic importance of altered bile salt metabolism

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980011-3

7 January 2021

Post-arsenical obstructive jaundice complicated by xanthomatosis and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980011-3

7 January 2021

Intrahepatic cholestasis due to N-propyl ajmaline

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980011-3

7 January 2021

Evaluation of prajmalium-induced cholestasis by immunologic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980011-3

7 January 2021

Prajmalium bitartrat-induced liver damage (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980011-3

7 January 2021

10.1016/S0168-8278(86)80011-3

Identifiers

DOI

1 reference

23 September 2017

1 reference